Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220 9. S3.14.1-2. Zomer AC, Vaartjes I, van der Velde ET, et al. Heart failure admis- sions in adults with congenital heart disease; risk factors and prog- nosis. Int J Cardiol. 2013;168:2487 93. S3.14.1-3. Oechslin EN, Harrison DA, Connelly MS, et al. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86:1111 6. S3.14.1-4. Zomer AC, Vaartjes I, Uiterwaal CSPM, et al. Circumstances of death in adult congenital heart disease. Int J Cardiol. 2012;154:168 72. S3.14.1-5. Stout K, Valente AM, Bartz PJ, et al. Task Force 6: pediatric car- diology fellowship training in adult congenital heart disease. Circulation. 2015;132:e91 8. S3.14.1-6. Norozi K, Bahlmann J, Raab B, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young. 2007;17:372 9. S3.14.1-7. Babu-Narayan SV, Uebing A, Davlouros PA, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary re- gurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012;154:299 305. S3.14.1-8. Lester SJ, McElhinney DB, Viloria E, et al. Effects of losartan in patients with a systemically functioning morphologic right ven- tricle after atrial repair of transposition of the great arteries. Am J Cardiol. 2001;88:1314 6. S3.14.1-9. Hechter SJ, Fredriksen PM, Liu P, et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001;87:660 3. A11. S3.14.1-10. Dore A, Houde C, Chan K-L, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a mul- ticenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112:2411 6. S3.14.1-11. 